hero image
Farhad Dastmalchi - University of Florida. Gainesville, FL, US

Farhad Dastmalchi Farhad Dastmalchi

Assistant Scientist | University of Florida

Gainesville, FL, UNITED STATES

Farhad Dastmalchi's research has focused on the development of immunotherapy vaccines.


Farhad Dastmalchi has developed a novel vaccines that have resulted in improved survival through his research in developing immunotherapy vaccines. He is an assistant scientist with the Preston A. Wells Jr. Center for Brain Tumor Therapy in order to focus on developing novel approaches to target and treat brain tumors.

Areas of Expertise (5)

Biomarker Discovery

Cancer Vaccine Development


Cancer Immunology

Cancer Metabolomics


Articles (3)

Glioma Immunotherapy: Advances and Challenges for Spinal Cord Gliomas

Spine and Spinal Cord Tumors

Clare Grady, et al.


Spinal cord gliomas are rare entities that often have limited surgical options. Immunotherapy has shown promise in intracranial gliomas with some research suggesting benefit for spinal cord gliomas. A focused review of immunotherapies that have been investigated in spinal cord gliomas was performed. The primary methods of immunotherapy investigated in spinal cord gliomas include immune checkpoint inhibitors, adoptive T-cell therapies, and vaccine strategies.

view more

Contemporary RNA Therapeutics for Glioblastoma

NeuroMolecular Medicine

Kaitlyn Melnick, et al.


Glioblastoma (GBM) is the most common primary brain tumor in adults and is universally lethal with a median survival of less than two years with standard therapy. RNA-based immunotherapies have significant potential to establish a durable treatment response for malignant brain tumors including GBM. RNA offers clear advantages over antigen-focused approaches but cannot often be directly administered due to biological instability.

view more

Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy

Cancer Metabolism

Farhad Dastmalchi, et al.


Immunotherapy has revolutionized care for many solid tissue malignancies, and is being investigated for efficacy in the treatment of malignant brain tumors. Identifying a non-invasive monitoring technique such as metabolomics monitoring to predict patient response to immunotherapy has the potential to simplify treatment decision-making and to ensure therapy is tailored based on early patient response.

view more